4th Quarter - Report

RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus.

LobbyistCovered position, as disclosed
MATTHEW BERZOK —
NICK KOLOVOS —
JEFF MACKINNON —
THOMAS RYAN —
JOSEPH V VASAPOLI —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1 (111th)

Food Industry (safety, labeling, etc.) FOO

Monitor food safety and supply chain issues.

LobbyistCovered position, as disclosed
MATTHEW BERZOK —
NICK KOLOVOS —
JEFF MACKINNON —
THOMAS RYAN —
JOSEPH V VASAPOLI —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

Physician payment disclosure including S. 301; Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for Americans Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Savings Medicines Act; H.R. 3962, Affordable Health Care for America Act; Comparative effectiveness legislation including S. 1213; Patient-Centered Outcomes Research Act of 2009; H.R. 3200, America's Health Future Act; H.R. 1548- Pathway for Dissimilar Act; Legislative changes in the health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act."; S. 1679, Affordable Health Choice Act; S. 1796, America's Healthy Future Act of 2009; Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
MATTHEW BERZOK —
NICK KOLOVOS —
JEFF MACKINNON —
THOMAS RYAN —
JOSEPH V VASAPOLI —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 3200 (111th), S. 1796 (111th), S. 1213 (111th), H.R. 3962 (111th), H.R. 1548 (111th), S. 726 (111th), S. 1679 (111th), H.R. 154 (111th), S. 301 (111th), H.R. 1427 (111th), H.R. 3590 (111th), H.R. 4872 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.